Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer

Shinichi Kageyama, Hiroaki Ikeda, Yoshihiro Miyahara, +20

Clinical Cancer Research

Safety and persistence of WT1-specific T-cell receptor gene−transduced lymphocytes in patients with AML and MDS

Isao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, +21

Blood

Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte

Ikuei Nukaya, Masazumi Yasumoto, Tomoko Iwasaki, +5

International Journal of Cancer

Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen

Tsuyoshi Itoh, Yuji Ueda, Ichiro Kawashima, +12

Cancer Immunology Immunotherapy

Cancer ImmunosurveillanceSolid CancerImmunologyTherapeutic VaccineHla-a24-restricted Peptide +6

Dendritic cell-based immunotherapy of cancer with carcinoembryonic antigen-derived, HLA-A24-restricted CTL epitope: Clinical outcomes of 18 patients with metastatic gastrointestinal or lung adenocarcinomas

Yuji Ueda, Tsuyoshi Itoh, Ikuei Nukaya, +15

International Journal of Oncology

ImmunologyPathologyImmunotherapeuticsGenerated DcsImmune Cell Therapy +20

Enhancement of cytotoxic T-lymphocyte responses in patients with gastrointestinal malignancies following vaccination with CEA peptide?pulsed dendritic cells

Kenji Matsuda, Takuya Tsunoda, Hajime Tanaka, +5

Cancer Immunology Immunotherapy

VaccinationCancer ImmunosurveillanceCea PeptideCytotoxic T-lymphocyte ResponsesImmunology +9

NY-ESO-1-specific redirected T cells with endogenous TCR knockdown mediate tumor response and cytokine release syndrome

Mikiya Ishihara, Shigehisa Kitano, Shinichi Kageyama, +23

Journal for ImmunoTherapy of Cancer

Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells

Yasuto Akiyama, Ryuji Tanosaki, Naoki Inoue, +10

Journal of Translational Medicine

Screening of HLA-A24-restricted epitope peptides from prostate-specific membrane antigen that induce specific antitumor cytotoxic T lymphocytes.

Yutaka Horiguchi, Ikuei Nukaya, Kazuhide Okazawa, +6

PubMed

In vivo persistence of genetically modified T cells generated ex vivo using the fibronectin CH296 stimulation method

S S Yu, Ikuei Nukaya, Tatsuji Enoki, +10

Cancer Gene Therapy

Cell TherapyT CellsMedicineT-regulatory CellImmunology +6